InMed Pharmaceuticals Inc INM

Healthcare Cannabis

InMed Pharmaceuticals Inc. is a clinical-stage pharmaceutical company. The Company is engaged in developing a pipeline of prescription-based products, including rare cannabinoids and cannabinoid analogs, targeting the treatment of diseases with high unmet medical needs, as well as developing proprietary manufacturing technologies to produce rare cannabinoids for sale in the health and wellness industry. Its segments include InMed Pharmaceuticals and BayMedica. The InMed Pharmaceuticals segment is engaged in research and development of cannabinoid-based pharmaceutical products. The BayMedica segment is focused on developing manufacturing technologies to produce rare cannabinoids for sale in the health and wellness industry. Its two product candidates include INM-755 and INM-088. INM-755 is developed as a topical skin cream formulation containing cannabinol (CBN) for the treatment of symptoms related to Epidermolysis Bullosa (EB). INM-088 is used for the treatment of glaucoma.

NDAQ:INM - Post by User

InMed Pharmaceuticals Inc

<< Previous

Bullboard Posts

Next >>

Post by Bullknit101on Jul 23, 2020 12:38pm

152 Views

Post# 31308491

Fear Cycle

This really is a test today, but likely the underwriters are keeping the SP low before the IPO. They can offer their buddies the best price, while us retail investors get raked over the coals. Good luck to gutsy investors! https://images.app.goo.gl/HLEGJrsMvbScQMZy6

<< Previous

Bullboard Posts

Next >>

This junior mining stock offers billions in market exposure